Fundraising FoxSectoral Asset Management — 2021 Investments
1 investments dated 2021 · listed companies and verified rows first · show all
Amolyt Pharmaamolytpharma.comSep 2021 · $138M
Developing therapeutic peptides targeting rare endocrine diseases (past investment).
Co-investorsAndera PartnersATEM Capital FundCTI Life Sciences Fund L.P.EQT Life SciencesKurma PartnersLSP (Life Sciences Partners)+5 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.